Medtronic Plc (2M6)
TG
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Mr. Matthew R. WalterSVP of HR, IT and Global Communications & Corporate Marketing | 9.15k | 0.00 | Derivative Exercise and Retained Stock | - | 33.80k | 37.12% |
| 2026-05-26 | Mr. Geoffrey Straub MarthaChairman of the Board & CEO | 94.96k | 0.00 | Derivative Exercise and Retained Stock | - | 231.40k | 69.60% |
| 2026-05-26 | Mr. Michael MarinaroExec. VP and President of Medical Surgical Portfolio & Americas | 18.99k | 0.00 | Derivative Exercise and Retained Stock | - | 32.17k | 144.12% |
| 2026-05-26 | Mr. Brett A. WallExecutive Officer | 26.91k | 0.00 | Derivative Exercise and Retained Stock | - | 48.34k | 125.56% |
| 2026-05-26 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | 15.20k | 0.00 | Derivative Exercise and Retained Stock | - | 17.24k | 744.12% |
| 2026-05-26 | Ms. Denise L. BlomquistVP, Global Controller & CAO | 1.71k | 0.00 | Derivative Exercise and Retained Stock | - | 6.81k | 33.61% |
| 2026-05-01 | Mr. Matthew R. WalterSVP of HR, IT and Global Communications & Corporate Marketing | -35.00 | 2.80k | Sale to Issuer | 80.00 | 24.55k | -0.14% |
| 2026-04-28 | Ms. Denise L. BlomquistVP, Global Controller & CAO | -318.00 | 26.04k | Sale to Issuer | 81.90 | 5.09k | -5.88% |
| 2026-04-28 | Mr. Kendall J. PowellIndependent Director | -207.00 | 16.95k | Sale to Issuer | 81.90 | 24.04k | -0.85% |
| 2026-04-28 | Dr. Elizabeth G. NabelIndependent Director | -207.00 | 16.95k | Sale to Issuer | 81.90 | 17.47k | -1.17% |
| 2026-04-28 | Mr. Kevin E. LoftonIndependent Director | -207.00 | 16.95k | Sale to Issuer | 81.90 | 8.03k | -2.51% |
| 2026-04-28 | Mr. Gregory Peter LewisIndependent Director | -207.00 | 16.95k | Sale to Issuer | 81.90 | 3.64k | -5.38% |
| 2026-04-28 | Mr. Randall J. HoganIndependent Director | -207.00 | 16.95k | Sale to Issuer | 81.90 | 46.89k | -0.44% |
| 2026-04-28 | Mr. Scott C. DonnellyIndependent Director | -207.00 | 16.95k | Sale to Issuer | 81.90 | 21.57k | -0.95% |
| 2026-04-28 | Ms. Lidia L. FonsecaIndependent Director | -207.00 | 16.95k | Sale to Issuer | 81.90 | 5.53k | -3.61% |
| 2026-04-28 | Mr. Craig ArnoldLead Independent Director | -207.00 | 16.95k | Sale to Issuer | 81.90 | 40.07k | -0.51% |
| 2026-03-03 | Mr. Thierry PietonExec. VP & CFO | -2.98k | 287.81k | Sale to Issuer | 96.71 | 6.96k | -29.96% |
| 2026-02-19 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | -50.88k | 346.52k | Derivative Exercise and Sale | 80.00 - 97.86 | 1.77k | - |
| 2026-02-19 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | -1.65k | 161.18k | 売り | 97.77 - 97.83 | 1.77k | -48.19% |
| 2026-02-20 | Ms. Denise L. BlomquistVP, Global Controller & CAO | -340.00 | 0.00 | Other Disposition | - | 4.31k | -7.31% |
| 2026-01-29 | Ms. Denise L. BlomquistVP, Global Controller & CAO | -148.00 | 14.95k | Sale to Issuer | 101.00 | 4.65k | -3.08% |
| 2025-12-15 | Mr. Brett A. WallExecutive Officer | -439.00 | 43.84k | Sale to Issuer | 99.87 | 20.90k | -2.06% |
| 2025-12-15 | Mr. Michael MarinaroExec. VP and President of Medical Surgical Portfolio & Americas | -1.37k | 136.92k | Sale to Issuer | 99.87 | 12.40k | -9.96% |
| 2025-12-15 | Mr. Geoffrey Straub MarthaChairman of the Board & CEO | -1.56k | 156.20k | Sale to Issuer | 99.87 | 134.70k | -1.15% |
| 2025-12-05 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | -1.70k | 172.51k | Sale to Issuer | 101.36 | 3.18k | -34.86% |
| 2025-11-20 | Ms. Denise L. BlomquistVP, Global Controller & CAO | -170.00 | 0.00 | Other Disposition | - | 4.31k | -3.79% |
| 2025-11-19 | Mr. Gregory L. Smithインサイダー | -30.00k | 3.06M | 売り | 101.93 - 102.08 | 36.23k | -45.30% |
| 2025-09-03 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | -8.61k | 788.05k | 売り | 91.58 - 91.59 | 2.42k | -78.06% |
| 2025-08-22 | Mr. William R. JellisonIndependent Director | 5.00k | 462.75k | 買い | 92.37 - 92.73 | 5.00k | - |
| 2025-08-20 | Mr. Michael MarinaroExec. VP and President of Medical Surgical Portfolio & Americas | -1.05k | 98.07k | Sale to Issuer | 93.22 | 13.52k | -7.22% |
| 2025-08-01 | Mr. Matthew R. WalterSVP of HR, IT and Global Communications & Corporate Marketing | 1.23k | 6.55k | Derivative Exercise and Retained Stock | 78.00 | 24.02k | 5.41% |
| 2025-08-01 | Mr. Matthew R. WalterSVP of HR, IT and Global Communications & Corporate Marketing | -1.91k | 102.08k | Derivative Exercise and Sale | 78.00 - 89.34 | 24.02k | - |
| 2025-08-01 | Mr. Brett A. WallExecutive Officer | 3.66k | 0.00 | Derivative Exercise and Retained Stock | - | 21.09k | 20.96% |
| 2025-08-01 | Mr. Brett A. WallExecutive Officer | -11.59k | 1.04M | Derivative Exercise and Sale | 89.34 | 21.09k | - |
| 2025-08-01 | Mr. Geoffrey Straub MarthaChairman of the Board & CEO | 21.15k | 218.56k | Derivative Exercise and Retained Stock | 78.00 | 135.43k | 18.51% |
| 2025-08-01 | Mr. Geoffrey Straub MarthaChairman of the Board & CEO | -77.18k | 3.95M | Derivative Exercise and Sale | 78.00 - 89.34 | 135.43k | - |
| 2025-08-01 | Mr. Gregory L. Smithインサイダー | 4.21k | 0.00 | Derivative Exercise and Retained Stock | - | 25.59k | 19.72% |
| 2025-08-01 | Mr. Gregory L. Smithインサイダー | -7.11k | 635.56k | Derivative Exercise and Sale | 89.34 | 25.59k | - |
| 2025-08-01 | Mr. Michael MarinaroExec. VP and President of Medical Surgical Portfolio & Americas | 1.90k | 20.44k | Derivative Exercise and Retained Stock | 78.00 | 14.57k | 14.98% |
| 2025-08-01 | Mr. Michael MarinaroExec. VP and President of Medical Surgical Portfolio & Americas | -7.76k | 470.15k | Derivative Exercise and Sale | 78.00 - 89.34 | 14.57k | - |
| 2025-08-01 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | 2.90k | 0.00 | Derivative Exercise and Retained Stock | - | 11.02k | 35.73% |
| 2025-08-01 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | -7.56k | 674.96k | Derivative Exercise and Sale | 89.34 | 11.02k | - |
| 2025-08-01 | Ms. Denise L. BlomquistVP, Global Controller & CAO | 460.00 | 16.69k | Derivative Exercise and Retained Stock | 78.00 | 4.38k | 11.73% |
| 2025-08-01 | Ms. Denise L. BlomquistVP, Global Controller & CAO | -58.00 | 5.18k | Derivative Exercise and Sale | 89.34 | 4.38k | - |
| 2025-08-01 | Ms. Denise L. BlomquistVP, Global Controller & CAO | -457.00 | 40.83k | Sale to Issuer | 89.34 | 4.38k | -9.45% |
| 2025-07-31 | Mr. Gregory L. Smithインサイダー | -1.63k | 147.09k | Sale to Issuer | 90.24 | 21.37k | -7.09% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。